• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kalbe Farma Tbk PT

+ Add to Watchlist

LCLA:GR

0.120 EUR 0.013 12.15%

As of 10:42:24 ET on 12/22/2014.

Snapshot for Kalbe Farma Tbk PT (LCLA)

Open: 0.113 Day's Range: 0.100 - 0.120 Volume: 0
Previous Close: 0.107 52wk Range: 0.065 - 0.128 1-Yr Rtn: +78.50%

Stock Chart for LCLA

No chart data available.
  • LCLA:GR 0.120
  • 1D
  • 1M
  • 1Y
0.107
Interactive LCLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LCLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 40.4764
Relative P/E vs. DAX -
Earnings Per Share (IDR) (ttm) -
Est. EPS (IDR) (12/2014) 45.2590
Est. PEG Ratio 3.2761
Market Cap (M EUR) 5,625.01
Shares Outstanding (M) 46,875.12
30 Day Average Volume 37,685
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.88%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 42.80%
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LCLA

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for LCLA

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for LCLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil